Olimab 60mg Injection contains Denosumab, a monoclonal antibody used primarily in the treatment of bone-related conditions.
Brand Name: Olimab
Composition: Denosumab
Mechanism of Action:
Denosumab is a RANK ligand (RANKL) inhibitor that binds to and inactivates RANKL, a protein essential for the formation, function, and survival of osteoclasts (cells that break down bone). By inhibiting RANKL, Denosumab reduces bone resorption and increases bone density, thereby lowering the risk of fractures.
Uses:
· Osteoporosis
· Bone Loss
· Giant Cell Tumor of Bone
· Hypercalcemia of Malignancy
Dosage and Administration:
60 mg subcutaneously once every 6 months for osteoporosis; other conditions may have different dosing schedules. Administered as a subcutaneous injection in the upper arm, upper thigh, or abdomen.
Side Effects:
· Back pain
· Musculoskeletal pain
· High cholesterol
· Urinary tract infections
· Rash
· Hypocalcemia (low blood calcium levels)
· Osteonecrosis of the jaw
· Femur fractures
· Hair loss
· Nerve Pain
Safety Advise:
Kidney 
Those with serious kidney problems should take Olimab 60 Injection carefully. It could be necessary to modify the dosage of Olimab 60 Injection. Kindly speak with your Healthcare provider.
Liver 
Those with serious liver problems should take Olimab 60 Injection carefully. It could be necessary to modify the dosage of Olimab 60 Injection. Kindly speak with your Healthcare provider.
Pregnancy 
Contraindicated in pregnancy due to the risk of fetal harm. Kindly speak with your Healthcare provider.
Breast Feeding 
Given that the medication may enter the breast milk and injure the unborn child, Olimab 60 Injection is most likely dangerous to use while nursing. Kindly speak with your Healthcare provider.
Alcohol 
When using Olimab 60 Injection with alcohol, caution is recommended. Kindly speak with your Healthcare provider.
Storage:
Store in a refrigerator at 2°C to 8°C. Do not freeze. Keep in the original packaging to protect from light and out of reach of children.
How to use this Medication?
This medication is injected subcutaneously. It is delivered at a hospital or clinic by a medical professional.
You will receive a personalized MedGuide prior to every treatment. Every time, make sure to carefully read this information.
Consult your pediatrician about Prolia and the usage of this medication in young patients. There might be a need for extra caution. Consult your physician about the usage of Xgeva in young patients. Precautions do apply even though this medication may be administered for specific diseases to youngsters as young as 13 years old.
References:
1. Hanley DA, Adachi JD, Bell A, Brown V. Denosumab: mechanism of action and clinical outcomes. International journal of clinical practice. 2012 Dec;66(12):1139-46.
2. Pageau SC. Denosumab. InMAbs 2009 May 1 (Vol. 1, No. 3, pp. 210-215). Taylor & Francis.
3. Cummings SR, Martin JS, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. New England Journal of Medicine. 2009 Aug 20;361(8):756-65.
4. Narayanan P. Denosumab: A comprehensive review. South Asian journal of cancer. 2013 Oct;2(04):272-7.
Disclaimer:
The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.
Marketer details
Name: Intas Pharmaceuticals Ltd
Address: Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.
Country of origin: India
Frequently Asked Questions (FAQs):
1. What is Olimab 60mg Injection?
Olimab 60mg contains Denosumab, a biological therapy. It may be prescribed for the treatment of osteoporosis in high-risk patients. It is crucial to strictly adhere to the treatment plan outlined by your specialist.
2. How may Olimab work?
It is believed to target a protein (RANKL) that controls bone breakdown. By inhibiting this, it may potentially slow bone loss and increase bone density over time.
3. What conditions may it be prescribed for?
It may be considered for postmenopausal women and men with osteoporosis who are at a high risk for fractures, subject to a doctor's clinical assessment.
4. How is it administered?
It is typically administered as a subcutaneous injection by a healthcare professional. You must adhere to your doctor’s administration protocol.
5. How often is the injection given?
The standard recommended schedule is generally once every 6 months. It is vital to adhere strictly to your doctor's calendar and not miss these bi-annual appointments.
6. What are the possible side effects?
Patients may potentially experience back pain, pain in the extremities, or urinary tract infections. Report any concerning symptoms to your doctor immediately.
7. Is a calcium supplement necessary?
Your physician may recommend taking calcium and vitamin D to potentially prevent low blood calcium levels. Adhere exactly to their daily supplementation guidance.
8. Are there severe dental risks?
It carries a rare potential risk of osteonecrosis of the jaw. Adhering to routine dental check-ups and informing your dentist of this medication is highly recommended.
9. Can I delay a dose?
Delaying a dose may potentially lead to a rapid decline in bone density and increased fracture risk. Maintaining strict adherence to the 6-month schedule is mandated.
10. Can it be used during pregnancy?
It is generally contraindicated during pregnancy due to potential risks of fetal harm. Strict adherence to your doctor's family planning advice is required.
11. How should it be stored?
It should typically be stored in a refrigerator (2°C–8°C). If you are handling it, adhere to your pharmacist's storage guidelines carefully.
12. Is Olimab a prescription medicine?
Yes. It is a prescription-only medication requiring long-term adherence to an endocrinologist's or rheumatologist's care plan.
Medical Disclaimer:
Olimab 60mg Injection is a prescription-only medicine and must be used strictly under the supervision and guidance of a qualified healthcare professional. Do not self-medicate, alter the dosage, or discontinue use without consulting your doctor. The information provided here is for educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Individual results, benefits, and risks may vary. Always consult your physician before starting, changing, or stopping any medication.